InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the full record of transactions filed by McCann Corey, Chief Executive Officer. Officer active across 1 company, notably Pear Therapeutics, Inc.. In total, 3 disclosures have been recorded. Breakdown: 0 buy · 1 sell. Total volume traded: €36k. Activity tracked since 14 January 2023. The latest transaction was disclosed on 20 January 2023 (Cession). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations
McCann Corey is the President and CEO of Pear Therapeutics, Inc. He leads the company's operations and strategy, focusing on the development of innovative digital therapies. Corey has significant experience in the healthcare sector, contributing to improving care and innovation within the organization.